TGN1412 and The Lancet's solicitation of reports of phase I trials.
Chalmers
Iain
I
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D017321:Clinical Trials, Phase I as Topic; D006801:Humans; D010506:Periodicals as Topic; D017594:Publication Bias; D012042:Registries
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C509303:TGN-1412